THE
FAULT LINE
30 OCTOBER 2026
ISSUE #027
— TODAY'S FAULT LINE
The Economy Grew. The Market Got Pickier.
The US economy accelerated, yet its biggest stock indices fell. That looks contradictory until you see what happened underneath: many shares rose as investors became more demanding about the price and cost of growth.
MARKETS AT A GLANCE — 29 OCTOBER
S&P 500
7,720
▼ 0.3%
NASDAQ
26,185
▼ 1.4%
BRENT
~$115
▼ ~0.4%
GOLD
$4,031
▼ 0.5%
— MACRO THEME
Growth has to earn its place in a portfolio

Thursday’s US growth report gave investors a reason to look beyond recession fears. The economy expanded at a 3.4% annualised pace in the third quarter, up from 2.2% in the second. Consumer spending and investment helped drive the expansion. The economy was still creating business opportunities.

But a growing economy does not make every growth stock a good investment. Alphabet’s results showed why. Its cloud business expanded rapidly, yet the group spent more on capital projects than it generated in operating cash, leaving quarterly free cash flow at roughly minus $9 billion. That is the cash remaining after investment in assets such as servers and data centres. Investors marked the shares down because strong demand alone could not answer how much spending would be needed to sustain it.

The more revealing signal was what did not fall with Alphabet. Most US shares advanced even as the Nasdaq dropped about 1.4%, and the Russell 2000 index of smaller companies gained about 1%. Large companies have a bigger influence on the main indices, so a handful of heavyweights can pull the headline down while many businesses rise. This was evidence of investors finding alternatives, rather than abandoning shares across the board.

FAULT LINE INSIGHT
A weak headline index can conceal a wider choice of businesses delivering growth.

Eli Lilly supplied one such alternative. Quarterly revenue rose 39%, driven primarily by its diabetes and obesity medicines, and the company lifted its annual revenue outlook. Its shares rose. Meanwhile, software companies faced a tougher reception when their outlooks fell short of expectations. The distinction was not simply technology versus everything else: investors were testing whether the next stage of growth justified the price already paid for it.

That is a useful change in emphasis, but one session does not establish a lasting shift in market leadership. September inflation, measured by the US Central Bank’s preferred personal consumption expenditures (PCE) index, accelerated to 3.6% from a year earlier. Higher living costs can still squeeze customers and keep borrowing expensive. Our preference is to broaden the search for credible earnings, while checking each business’s spending needs and valuation. An attractive industry does not excuse an unattractive purchase price.

CAPITAL PRESSURE GAUGE
OVERALL PRESSURE: HIGH
Pressure is concentrated in expensive expectations and the cost of delivering growth. Improving participation elsewhere is a useful counterweight.
GROWTH EXPECTATIONSHIGH
Alphabet’s cash shortfall and the sharp falls in software shares show how quickly a strong growth story can lose support when spending or forecasts disappoint.
INFLATION PRESSUREHIGH
Annual PCE inflation accelerated to 3.6% in September. Customers’ budgets and companies’ financing plans still face pressure despite resilient economic growth.
MARKET BREADTHMODERATE
Most shares rose while the main indices fell. Wider participation argues against treating a technology sell-off as evidence that every part of the market is weakening.
BORROWING COSTSHIGH
The US 10-year government bond yield eased back below 5%. That helps at the margin, but borrowers still face costly financing; one day’s fall does not secure cheaper future loans.
— GEOPOLITICAL PULSE
Demand needs access as well as customers
MONGOLIA–CHINA • COPPER DELIVERIES
Oyu Tolgoi’s operator said copper-concentrate exports to China had fallen about 70% over two weeks because of restrictions at a border crossing. Market read: A mine’s output and the cash it can collect are different things. Transport access can delay sales even when customers need the metal.
US–CHINA • MEDICAL SUPPLY CHAINS
China condemned US additions of Chinese medical-equipment companies to a list tied to Washington’s allegations of forced labour or sourcing from Xinjiang. Market read: Healthcare demand does not remove trade risk. Buyers and investors need to check supplier eligibility and market access, while treating any further retaliation as a possibility rather than an announced outcome.
GULF • SECURITY AND COMMERCE
Reuters reported that ExxonMobil and Chevron cancelled planned executive trips to the UAE’s major oil conference next week, citing security concerns. Market read: The cancellations underline continuing regional security concerns. A small fall in Brent offers little evidence that business conditions across the region have normalised.
— THE CROWD
Buying the dip is no longer one trade
Thursday’s discussions revealed different reactions to falling technology shares and rising healthcare stocks. These are qualitative observations, not a market-wide sentiment survey.
GOOGL
ALPHABET
MIXED
During the session, expressions of frustration and further-downside bets sat alongside calls to buy the decline for the longer term.
Fault Line take: A lower share price can improve prospective returns. The question is whether the valuation now compensates for higher spending needs and uncertainty over future cash generation.
FTNT
FORTINET
MIXED
Overnight and early-Thursday discussion split between bargain hunters calling the fall excessive and traders questioning whether buying it meant catching a further decline.
Fault Line take: An earnings beat does not settle the outlook. Slower service growth and a reduced service-revenue forecast deserve scrutiny before a cheaper price is treated as value.
LLY
ELI LILLY
BULLISH
Intraday discussion celebrated the results and the rally, with some regret about missed gains. A smaller strand questioned whether the shares already priced in too much success.
Fault Line take: The demand evidence is strong. Investors still need to distinguish a business delivering excellent growth from a share offering an attractive return at its current price.
— ALLOCATION VIEW
Widen the search. Keep the standards.
ASSET / THEME · VIEW · FAULT LINE READ
US EquitiesNEUTRAL
Broader participation supports looking beyond the largest index names. Prefer evidenced earnings and sensible prices over a blanket retreat or indiscriminate buying.
AI InfrastructureOVERWEIGHT
Demand for equipment can remain strong while customers face cash shortfalls. Distinguish suppliers getting paid from capacity owners still funding expansion.
GoldOVERWEIGHT
Retain the strategic hedge, recognising its limits as a daily haven. December futures fell 0.5% as persistent inflation kept further tightening in focus.
CryptoNEUTRAL
A technology sell-off does not by itself create a compelling entry point. Require evidence specific to adoption, liquidity and the asset’s risk.
HealthcareOVERWEIGHT
Lilly’s revenue growth shows that powerful demand exists outside the AI buildout. Compare pricing, competition and valuations across the sector.
Short-Duration BondsOVERWEIGHT
Shorter maturities provide income with less sensitivity to changes in long-term rates. Retain flexibility while inflation complicates the policy outlook.
AI Adoption / SoftwareNEUTRAL
The software sell-off raises the bar for proving durable customer spending and profits. A reduced share price alone does not resolve disruption or forecast risk.
CopperOVERWEIGHT
Oyu Tolgoi’s export disruption reinforces the importance of delivery routes. Prefer producers able to convert demand and output into cash, allowing for access and execution risks.
— EDITOR'S NOTE
THE FAULT LINE · 30 OCTOBER 2026

A portfolio can hold many company names and still depend on one assumption: that a handful of technology customers will keep increasing their spending.

Different industries are useful when their profits depend on different customers, budgets and decisions. Medicines, software subscriptions and copper deliveries carry distinct risks; spreading money between them is only valuable if we understand those differences.

Thursday offered a reminder to look through the index and through the industry label. Diversification should widen the sources of earnings in a portfolio, while valuation discipline determines whether those earnings are worth buying.

Count the independent sources of profit, not just the number of holdings.
— The Fault Line